Abstract
The coronavirus disease 2019 (COVID-19) pandemic is currently a challenge worldwide. In Austria, a crisis within the healthcare system has so far been prevented. The treatment of patients with community-acquired pneumonia (CAP), including SARS-CoV‑2 infections, should continue to be based on evidence-based CAP guidelines during the pandemic; however, COVID-19 specific adjustments are useful. The treatment of patients with chronic lung diseases has to be adapted during the pandemic but must still be guaranteed.
| Original language | English |
|---|---|
| Pages (from-to) | 365-386 |
| Number of pages | 22 |
| Journal | Wiener Klinische Wochenschrift |
| Volume | 132 |
| Issue number | 13-14 |
| DOIs | |
| Publication status | Published - 01 Jul 2020 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Adolescent
- Adult
- Austria
- Betacoronavirus
- COVID-19
- Child
- Chronic Disease
- Coronavirus
- Coronavirus Infections/complications
- Humans
- Lung Diseases/complications
- Pandemics
- Pneumonia, Viral/complications
- Practice Guidelines as Topic
- Pulmonary Medicine
- SARS-CoV-2
Fingerprint
Dive into the research topics of 'Management of patients with SARS-CoV-2 infections and of patients with chronic lung diseases during the COVID-19 pandemic (as of 9 May 2020): Statement of the Austrian Society of Pneumology (ASP)'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver